Details werden geladen...
Deep dive: The oral obesity wars - BioSpace
BioSpace examines how the FDA approval of Eli Lilly’s oral obesity drug Foundayo has ignited a key race with Novo Nordisk.
Ähnliche Seiten
Amgen’s rare disease drug Tavneos tied to 20 deaths in Japan - BioSpace
https://www.biospace.com/business/amgens-rare-disease-drug-tavneos-tied-to-20-deaths-in-japan
Tech Trends Deep Dive: Tech Experiments - Silverchair
https://www.silverchair.com/news/tech-experiments/FDA alignment is critical to serving the rare disease community. AI can help - BioSpace
https://www.biospace.com/drug-development/opinion-fda-alignment-is-critical-to-serving-the-rare-disease-community-ai-can-help
Deep Dive into OpenCode Agent Orchestration - DEV Community
https://dev.to/joaomelo-tech/deep-dive-into-opencode-agent-orchestration-3ocdLilly and Engage Bio tie the knot with $202M acquisition - BioSpace
https://www.biospace.com/deals/lilly-and-engage-bio-tie-the-knot-with-202m-acquisition